Stephen K. Doberstein
2013
In 2013, Stephen K. Doberstein earned a total compensation of $1.2M as Senior Vice President and Chief Scientific Officer at Nektar Therapeutics, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $231,000 |
|---|---|
| Option Awards | $459,370 |
| Salary | $459,722 |
| Other | $9,513 |
| Total | $1,159,605 |
Doberstein received $459.7K in salary, accounting for 40% of the total pay in 2013.
Doberstein also received $231K in non-equity incentive plan, $459.4K in option awards and $9.5K in other compensation.
Rankings
In 2013, Stephen K. Doberstein's compensation ranked 5,971st out of 12,286 executives tracked by ExecPay. In other words, Doberstein earned more than 51.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,971 out of 12,286 | 51st |
Division Manufacturing | 2,071 out of 4,614 | 55th |
Major group Chemicals And Allied Products | 607 out of 1,466 | 59th |
Industry group Drugs | 437 out of 1,160 | 62nd |
Industry Pharmaceutical Preparations | 350 out of 890 | 61st |
Source: SEC filing on April 30, 2015.
Doberstein's colleagues
We found four more compensation records of executives who worked with Stephen K. Doberstein at Nektar Therapeutics in 2013.